A lawsuit was filed for investors in shares of Ignyta Inc (NASDAQ:RXDX) in connection with the proposed takeover and NASDAQ:RXDX stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 01/29/2018 -- The Shareholders Foundation announces that an investor, who currently holds shares of Ignyta Inc (NASDAQ: filed a lawsuit against the takeover of Ignyta Inc by Roche for $27.00 per share.
Investors inshares of Ignyta Inc (NASDAQ:RXDX) have certain options and should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 - 1554.
The plaintiff alleges that the defendants breached their fiduciary duties owed to NASDAQ:RXDX stockholders by agreeing to sell Ignyta Inc cheaply via an unfair process to Roche.
On December 22, 2017, Roche (SIX: RO, ROG; OTCQX: RHHBY) and Ignyta, Inc. (NASDAQ: RXDX) announced they have entered into a definitive merger agreement for Roche to fully acquire Ignyta at a price of US$ 27.00 per share in an all-cash transaction.
However, plaintiff claims that the proposed consideration NASDAQ: RXDX shareholders will receive is grossly inadequate and undervalues Ignyta, Inc. Indeed, at least one analyst has set the high target price for NASDAQ:RXDX shares at $31.00 per share. In addition, the plaintiff alleges that the process is also unfair NASDAQ: RXDX stockholders.
Those who are current investors in Ignyta Inc (NASDAQ:RXDX) shares have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
For more information on this press release visit:
Media Relations Contact
Email: Click to Email Michael Daniels